TCG Crossover
North America, California, United States, Palo Alto
Description
TCG Crossover is a healthcare investment firm dedicated to advancing disruptive medicines and supporting companies.
Investor Profile
TCG Crossover has made 55 investments, with 13 in the past 12 months and 35% as lead.
Stage Focus
- Post Ipo Equity (49%)
- Series B (24%)
- Series A (13%)
- Series C (11%)
- Series F (2%)
- Series E (2%)
Country Focus
- United States (80%)
- United Kingdom (11%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- France (4%)
- Switzerland (2%)
- Denmark (2%)
- China (2%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Life Science
- Biopharma
- Medical Device
- Genetics
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
